Current methods for attaching targeting ligands to liposomes and nanoparticles

被引:256
|
作者
Nobs, L
Buchegger, F
Gurny, R
Allémann, E
机构
[1] Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland
[2] Univ Hosp Geneva, Nucl Med Serv, CH-1211 Geneva 14, Switzerland
关键词
nanoparticle; liposome; active targeting; surface modification; antibody; drug targeting; carrier system; immunoliposome;
D O I
10.1002/jps.20098
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Liposomes and nanoparticles have emerged as versatile carrier systems for delivering active molecules in the organism. These colloidal particles have demonstrated enhanced efficacy compared to conventional drugs. However, the design of liposomes and nanoparticles with a prolonged circulation time and ability to deliver active compounds specifically to target sites remains an ongoing research goal. One interesting way to achieve active targeting is to attach ligands, such as monoclonal antibodies or peptides, to the carrier. These surface-bound ligands recognize and bind specifically to target cells. To this end, various techniques have been described, including covalent and noncovalent approaches. Both in vitro and in vivo studies have proved the efficacy of the concept of active targeting. The present review summarizes the most common coupling techniques developed for binding homing moieties to the surface of liposomes and nanoparticles. Various coupling methods, covalent and noncovalent, will be reviewed, with emphasis on the major differences between the coupling reactions, on their advantages and drawbacks, on the coupling efficiency obtained, and on the importance of combining active targeting with long-circulating particles. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:1980 / 1992
页数:13
相关论文
共 50 条
  • [1] Nanoparticles and liposomes for drug targeting
    Fattal, E
    Alphandary, H
    Weingarten, C
    Vauthier, C
    Dubernet, C
    Andremont, A
    Couvreur, P
    FUTURE STRATEGIES FOR DRUG DELIVERY WITH PARTICULATE SYSTEMS, 1998, : 1 - 4
  • [2] Nanoparticles as targeting ligands
    Jain, KK
    TRENDS IN BIOTECHNOLOGY, 2006, 24 (04) : 143 - 145
  • [3] Engineering Liposomes and Nanoparticles for Biological Targeting
    Jolck, Rasmus I.
    Feldborg, Lise N.
    Andersen, Simon
    Moghimi, S. Moein
    Andresen, Thomas L.
    BIOFUNCTIONALIZATION OF POLYMERS AND THEIR APPLICATIONS, 2011, 125 : 251 - 280
  • [4] A NONCOVALENT METHOD OF ATTACHING ANTIBODIES TO LIPOSOMES
    LOUGHREY, H
    BALLY, MB
    CULLIS, PR
    BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 901 (01) : 157 - 160
  • [5] Current trends in the use of liposomes for tumor targeting
    Deshpande, Pranali P.
    Biswas, Swati
    Torchilin, Vladimir P.
    NANOMEDICINE, 2013, 8 (09) : 1509 - 1528
  • [6] Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
    Rukavina, Zora
    Vani, Zeljka
    PHARMACEUTICS, 2016, 8 (02)
  • [7] Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain
    van Rooy, Inge
    Mastrobattista, Enrico
    Storm, Gert
    Hennink, Wim E.
    Schiffelers, Raymond M.
    JOURNAL OF CONTROLLED RELEASE, 2011, 150 (01) : 30 - 36
  • [8] TARGETING OF LIPOSOMES BY COVALENT COUPLING WITH ECTO-NAD+-GLYCOHYDROLASE LIGANDS
    SALORD, J
    TARNUS, C
    MULLER, CD
    SCHUBER, F
    BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 886 (01) : 64 - 75
  • [9] A NEW METHOD FOR ATTACHING LIGANDS TO POLYSACCHARIDES
    MOLOTKOVSKAYA, IM
    LYASHENKO, VA
    MOLOTKOVSKY, JG
    BIOORGANICHESKAYA KHIMIYA, 1984, 10 (07): : 954 - 956
  • [10] Enhanced Active Targeting via Cooperative Binding of Ligands on Liposomes to Target Receptors
    Sugiyama, Tomoki
    Asai, Tomohiro
    Nedachi, Yuki Murase
    Katanasaka, Yasufumi
    Shimizu, Kosuke
    Maeda, Noriyuki
    Oku, Naoto
    PLOS ONE, 2013, 8 (06):